This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ZR2 Bioenergy Ltd reported audited financial results for FY ended March 2026. The company recorded zero revenue from operations (down from Rs. 149.45 lakhs in FY2025), with total income of Rs. 183.82 lakhs coming primarily from other income (Rs. 183.82 lakhs) - a 195% increase in other income year-on-year. Standalone profit after tax surged to Rs. 70.48 lakhs from Rs. 8.22 lakhs (757% growth), while consolidated PAT jumped to Rs. 100.43 lakhs from Rs. 9.02 lakhs (1,013% growth). EPS (basic) improved to Rs. 1.97 from Rs. 0.23. The company is transitioning into bioenergy, agri-commodities and agro-products with an ethanol plant acquisition in advanced stages. Convertible warrants worth Rs. 4,212.33 lakhs were forfeited due to non-exercise by allottees. The auditors issued unqualified opinions with no going concern doubts. Cash and cash equivalents stand at Rs. 1,884 lakhs.
The stock shows strong profitability metrics despite zero operational revenue, driven by other income and warrant forfeiture gains. The transition to bioenergy remains in pre-commercial phase with capital work-in-progress at Rs. 12,011 lakhs. Negative operating cash flow of Rs. 60.65 lakhs indicates ongoing cash burn before commercial operations begin, which investors should monitor.